Traders Anticipate Potential 6% Move in Eli Lilly Stock Following Earnings Report
Eli Lilly (LLY) is set to report earnings, with traders expecting a potential 6% move in either direction by the end of the week. The stock has already fallen 20% year-to-date, and investors are closely watching updates on the company's new weight-loss pill, Foundayo, and its competition with Novo Nordisk's Wegovy (NVO).
Topics: Earnings Market Outlook Stock Price Movement Weight-loss Drug